
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
S-Adenosyl-L-Methionine (SAMe) is a naturally occurring methyl donor compound that supports neurotransmitter synthesis and liver function through transmethylation and transsulfuration pathways. SAMe enhances serotonin and dopamine production while promoting glutathione synthesis for liver detoxification.

Reported Benefits (Provisional)
Origin & History

S-Adenosyl-L-Methionine (SAMe) is a naturally occurring compound formed from methionine and ATP. It is found in every cell of the body and is synthesized for supplements to support various health functions.
Research Narrative (Provisional)
Numerous RCTs and meta-analyses support SAMe's efficacy in mood enhancement and joint health, with a strong evidence base for its use in depression and osteoarthritis.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Derivative of methionine and ATP. - Involved in methylation processes. - Found in all living cells.
Reported Mechanism (Provisional)
SAMe functions as a universal methyl donor in transmethylation reactions, facilitating the synthesis of neurotransmitters including serotonin, dopamine, and norepinephrine through catechol-O-methyltransferase (COMT) pathways. In the liver, SAMe undergoes transsulfuration to produce cysteine and glutathione, supporting phase II detoxification enzymes. SAMe also methylates phosphatidylethanolamine to form phosphatidylcholine, maintaining cellular membrane fluidity and integrity.
Clinical Narrative (Provisional)
Multiple randomized controlled trials involving over 1,400 participants demonstrate SAMe's efficacy for depression, with response rates of 60-70% at doses of 800-1600mg daily. Liver studies show SAMe (800-1200mg daily) significantly improves ALT and AST levels in patients with alcoholic liver disease and intrahepatic cholestasis. Osteoarthritis trials indicate SAMe (1200mg daily) provides pain relief comparable to NSAIDs with fewer gastrointestinal side effects. However, most studies are small-scale with 4-12 week durations, requiring larger long-term trials for definitive conclusions.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







